Drug-related AEs grade ≥3
AE . | Dose (mg/m2 per day) . | N (%) . |
---|---|---|
Patients with ≥1 drug-related TEAE ≥ grade 3 | All | 9 (18) |
Leukocytosis | 36, 80, 90 | 3 (6) |
Cardiac failure congestive | 90 | 2 (4) |
Cardiac failure | 90 | 1 (2) |
Ejection fraction decreased* | 90 | 1 (2) |
Cardiorespiratory arrest* | 90 | 1 (2) |
Liver function test abnormal† | 54 | 1 (2) |
White blood cell count increased | 54 | 1 (2) |
Anemia | 54 | 1 (2) |
Electrocardiogram QT prolonged | 54 | 1 (2) |
Hypophosphatemia | 90 | 1 (2) |
AE . | Dose (mg/m2 per day) . | N (%) . |
---|---|---|
Patients with ≥1 drug-related TEAE ≥ grade 3 | All | 9 (18) |
Leukocytosis | 36, 80, 90 | 3 (6) |
Cardiac failure congestive | 90 | 2 (4) |
Cardiac failure | 90 | 1 (2) |
Ejection fraction decreased* | 90 | 1 (2) |
Cardiorespiratory arrest* | 90 | 1 (2) |
Liver function test abnormal† | 54 | 1 (2) |
White blood cell count increased | 54 | 1 (2) |
Anemia | 54 | 1 (2) |
Electrocardiogram QT prolonged | 54 | 1 (2) |
Hypophosphatemia | 90 | 1 (2) |